MDSCs protect cancer cells by suppressing immunosurveillance, promoting angiogenesis via the secretion of matrix metallopeptidase 9 (MMP9) and the vascular endothelial growth factor (VEGF), and inducing metastasis [8, 41]. The gene discussed is VEGFA; the disease is cancer.